For patients who are initially being listed for liver transplantation and for patients who are seeking to retain their active status on the wait list, the first step in the diagnostic consideration of hepatocellular carcinoma (HCC) is the accurate identification and staging of the tumors. Advances i
Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list
β Scribed by Mehta, Neil; Dodge, Jennifer L.; Roberts, John Paul; Hirose, Ryutaro; Yao, Francis Y.
- Book ID
- 127055827
- Publisher
- John Wiley and Sons
- Year
- 2014
- Tongue
- English
- Weight
- 124 KB
- Volume
- 20
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.23847
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The dropout from the waiting list for liver transplantation among patients with hepatocellular carcinoma (HCC) is reportedly as high as 12% to 40% per year, mostly due to tumor progression. Considering the scarcity of donor organs, it would be beneficial if we could retain them within the Milan crit
Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation, the rules governing priority and access to the waiting list are not well defined. Patient-and tumor-related variables were evaluated in 226 patients listed primarily for HCC in Belgium, a region whe